Anti-B-50 (GAP-43) antibodies decrease exocytosis of glutamate in permeated synaptosomes.

Hens, J J; Ghijsen, W E; Weller, U; Spierenburg, H A; Boomsma, F; Oestreicher, A B; Lopes da Silva, F H; De Graan, P N

Hens, J J; Ghijsen, W E; Weller, U; Spierenburg, H A; Boomsma, F; Oestreicher, A B; Lopes da Silva, F H; De Graan, P N.

Affiliation

Hens JJ; Department of Medical Pharmacology, Rudolf Magnus Institute for Neurosciences, Utrecht University, The Netherlands.

Eur J Pharmacol ; 363(2-3): 229-40, 1998 Dec 18.

Article in En | MEDLINE | ID: mdl-9881594

Subject(s)

Antibodies, Monoclonal/pharmacology; Exocytosis; GAP-43 Protein/metabolism; Glutamic Acid/metabolism; Synaptosomes/metabolism; Adenosine Triphosphate/metabolism; Animals; Calcium/metabolism; Enzyme Inhibitors/pharmacology; GAP-43 Protein/immunology; In Vitro Techniques; Intracellular Membranes/metabolism; Male; Norepinephrine/metabolism; Protein Kinase C/antagonists & inhibitors; Rats; Rats, Wistar; Streptolysins/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Synaptosomes / Glutamic Acid / GAP-43 Protein / Exocytosis / Antibodies, Monoclonal Limits: Animals Language: En Journal: Eur J Pharmacol Year: 1998 Document type: Article Affiliation country: Netherlands Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links